Year |
Citation |
Score |
2020 |
Cathala A, Devroye C, Robert É, Vallée M, Revest JM, Artigas F, Spampinato U. Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways. Neuropharmacology. 180: 108309. PMID 32956675 DOI: 10.1016/j.neuropharm.2020.108309 |
0.6 |
|
2019 |
Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/j.bbi.2019.06.006 |
0.36 |
|
2018 |
Cathala A, Devroye C, Drutel G, Revest JM, Artigas F, Spampinato U. Serotonin receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons. Experimental Neurology. 311: 57-66. PMID 30257183 DOI: 10.1016/j.expneurol.2018.09.015 |
0.6 |
|
2017 |
Devroye C, Cathala A, Piazza PV, Spampinato U. The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research. Pharmacology & Therapeutics. PMID 28757154 DOI: 10.1016/j.pharmthera.2017.07.014 |
0.6 |
|
2017 |
Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza PV, Artigas F, Spampinato U. Opposite controls of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors. Neuropharmacology. PMID 28390892 DOI: 10.1016/j.neuropharm.2017.04.001 |
0.6 |
|
2016 |
Devroye C, Cathala A, Haddjeri N, Rovera R, Vallée M, Drago F, Piazza PV, Spampinato U. Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia. Neuropharmacology. 109: 59-68. PMID 27260325 DOI: 10.1016/j.neuropharm.2016.05.024 |
0.6 |
|
2015 |
Devroye C, Cathala A, Di Marco B, Caraci F, Drago F, Piazza PV, Spampinato U. Central serotonin2B receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow. Neuropharmacology. 97: 329-37. PMID 26116760 DOI: 10.1016/j.neuropharm.2015.06.012 |
0.6 |
|
2015 |
Devroye C, Cathala A, Maitre M, Piazza PV, Abrous DN, Revest JM, Spampinato U. Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow. Neuropharmacology. 89: 375-81. PMID 25446572 DOI: 10.1016/j.neuropharm.2014.10.016 |
0.6 |
|
2015 |
Cathala A, Devroye C, Maitre M, Piazza PV, Abrous DN, Revest JM, Spampinato U. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. Addiction Biology. 20: 445-57. PMID 24661380 DOI: 10.1111/adb.12137 |
0.6 |
|
2013 |
Devroye C, Filip M, Przegaliński E, McCreary AC, Spampinato U. Serotonin2C receptors and drug addiction: focus on cocaine. Experimental Brain Research. 230: 537-45. PMID 23748692 DOI: 10.1007/s00221-013-3593-2 |
0.6 |
|
Show low-probability matches. |